VENTOLIN

This brand name is authorized in United States. It is also authorized in Australia, Canada, Croatia, Cyprus, Estonia, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug VENTOLIN contains one active pharmaceutical ingredient (API):

1	Salbutamol UNII 021SEF3731 - ALBUTEROL SULFATE
	Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases.
	Read more about Salbutamol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VENTOLIN Solution for inhalation via a nebuliser	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
VENTOLIN Syrup	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
VENTOLIN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AC02	Salbutamol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1103C, 11088N, 11095Y, 11125M, 11130T, 12108G, 12109H, 3495Y, 8288F
CA	Health Products and Food Branch	02213419, 02213427, 02213451, 02213486, 02241497, 02243115
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.376-03-02, 24.641-08-02, 24.828-11-02, 25.592-03-04, 497-MEE-1014, 6931-MEE-0122
EE	Ravimiamet	1004319, 1004948, 1005512, 1006423, 1031308
ES	Centro de información online de medicamentos de la AEMPS	53010, 53931, 53932, 55147, 55148
GB	Medicines & Healthcare Products Regulatory Agency	139675, 139690, 147510, 14794, 19076, 200311, 24712, 33820, 33832, 33873, 381729, 39270, 48441
HK	Department of Health Drug Office	02796, 07007, 26476, 42389
HR	Agencija za lijekove i medicinske proizvode	HR-H-659347356
IE	Health Products Regulatory Authority	52005, 52060, 52074, 52221, 53899, 55778, 68152, 68160, 74126, 74135
IL	מִשְׂרַד הַבְּרִיאוּת	290, 292, 4151, 4350, 4351
IT	Agenzia del Farmaco	022984052
LT	Valstybinė vaistų kontrolės tarnyba	1001947, 1002425, 1006578, 1012096, 1012097, 1078750, 1080799, 1086182, 1088354, 1088456, 1089751
MT	Medicines Authority	AA565/26305, MA192/03301, MA192/03302, MA192/03303, MA192/03304, PI1438/08301A, PI1438/08302A, PI521/00401C, PI565/26306A, PI908/01603A, PI908/01604A, PI908/01605A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	72948, 77849, 80307, 86514, 88021
NL	Z-Index G-Standaard	12304131, 12309605, 13488066, 14039354, 14127199, 14127202, 14162644, 14172348
NL	Z-Index G-Standaard, PRK	15067, 15539, 22098, 43281, 47708, 75124, 75272, 82465
NZ	Medicines and Medical Devices Safety Authority	1142, 1145, 1146, 1147, 1152, 1153
PL	Rejestru Produktów Leczniczych	100089356, 100090603, 100090610, 100256305, 100261996, 100436579
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64944001, W64944002, W65178001, W65179001
SG	Health Sciences Authority	02539P, 02988P, 05334P, 08211P, 08240P, 09425P, 11359P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522019281, 8699522521456, 8699522521494, 8699522571413
US	FDA, National Drug Code	0173-0682, 35356-166, 63187-026, 68071-1670, 68071-1890, 70518-1237, 72189-016
ZA	Health Products Regulatory Authority	31/10.2.1/0120, 32/10.2.1/0344, D/10.2.1/203, H/10.2.2/118, H/10.2.2/119